-
Prices Spike for Drugs Used to Treat Multiple Sclerosis
drugs
August 28, 2019
From 2006 to 2016, the prices of self-administered disease-modifying therapies (DMTs) for multiple sclerosis increased, according to a study published online in JAMA Neurology.
-
Switzerland found to be most innovative drug delivery market in Europe
europeanpharmaceuticalreview
August 27, 2019
According to new research, innovation in drug delivery is accelerating in Europe, with Switzerland as Europe’s biggest drug delivery innovator.
-
Brand-name drug prices found to be rising at a slower pace in lower amounts
europeanpharmaceuticalreview
August 23, 2019
Drug companies are still raising prices for brand-name prescription medicines but not as often or by as much as they used to.
-
Study finds lack of racial diversity in cancer drug clinical trials
worldpharmanews
August 20, 2019
New research published in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. The study - conducted by researchers from UBC, the University of Texas MD Anderson Cancer Center...
-
Silica-based drug delivery could improve anticancer drugs
europeanpharmaceuticalreview
August 19, 2019
Researchers have developed silica spheres to contain cancer therapeutics that melt at certain temperatures and have the potential to improve drug delivery.
-
Complete response letter sent for two generic products
europeanpharmaceuticalreview
August 19, 2019
A complete response letter (CRL) has been sent to Dr Reddy’s for two generic products.
-
New drug shows encouraging survival in pancreatic cancer
worldpharmanews
August 16, 2019
A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center.
-
Drug accelerates blood system's recovery after chemotherapy, radiation
worldpharmanews
August 16, 2019
A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem cells after exposure to radiation. If the results can be replicated in humans...
-
Letter highlights issues with US drug returns verification requirements
europeanpharmaceuticalreview
August 15, 2019
An open letter has underscored the challenges of return failure in the US drug supply chain, especially after the introduction of the Drug Supply Chain Security Act in November.
-
FDA to deactivate out-of-date drug listings in its database
europeanpharmaceuticalreview
August 15, 2019
In order keep up-to-date records and protect public health the FDA has announced it intends to deactivate out-of-date drug listings.